Journal of Physical Chemistry p. 10297 - 10302 (1992)
Update date:2022-08-10
Topics:
Hamanoue, Kumao
Nakayama, Toshihiro
Ikenaga, Koichiro
Ibuki, Kazuyasu
Steady-state photolysis of XA (9,10-dichloroanthracene and 9-chloroanthracene) in acetonitrile-amine (triethylamine or N,N-dimethylaniline) causes the consecutive reactions ( DCA -> CA -> anthracene), but the rate of dechlorination is affected upon addition of azulene and ferrocene in spite of quenching the lowest excited triplet state <3XA(T1)> of XA by these additives with quenching rate constants of the order for that of a diffusion-controlled reaction.Although not only the intensities of fluorescence spectra due to the lowest excited singlet states <1XA(S1)> of XA but also those of triplet-triplet absorption spectra due to 3XA(T1) decrease with increasing amine concentration, the appearance of absorption spectra due to the chloroanthracene radical anions (XA.-) within the duration of nanosecond pulse excitation has been attributed to the formation of singlet exciplexes <1(XA-amine)*> by a diffusion-controlled reaction of 1XA(S1) with ground-state amine followed by decomposition into XA.- and the amine radical cations.Since 3XA(T1) are quenched by amine in the microsecond time regime and no evidence supporting the participation of the triplet exciplexes of chloroanthracenes with amine in the dechlorination as proposed by Soloveichik et al. is obtained (cf. ref 2), we have concluded that XA.- produced via 1(XA-amine)* are the reaction intermediates for dechlorination of XA.
View MoreShangHai Original Economy-Trade Develop Co.,Ltd.,
Contact:86-21-68552131
Address:shanghai
suzhou unitop chemtech co.,ltd.
Contact:86-512 -58916316
Address:Xinhongji building 406, suzhou, China
Contact:+86-21-54391580
Address:Room 502,No.65,Lane 2388 Hongxin Road,Shanghai,China
Contact:+86-532-55689660
Address:qingdao
Hebei Fulong Import & Export Co., Ltd.
Contact:86-311-87795661
Address:15A19 Zhongyuan Building,368 Youyi North Street,Shijiazhuang 050070,China
Doi:10.1002/chir.23105
(2019)Doi:10.1248/cpb.59.1348
(2011)Doi:10.1016/j.farmac.2004.01.010
(2004)Doi:10.1080/10286020.2017.1305958
(2017)Doi:10.1007/s10870-021-00899-w
(2021)Doi:10.1016/S0040-4039(01)80193-3
(1984)